Identification of novel inhibitors from Urtica spp against TNBC targeting JAK2 receptor for breast cancer therapy.
Researchers discovered extracts from Urtica dioica and U. parviflora plants containing 12 compounds with better binding energy than Paclitaxel. These extracts showed promising anticancer activity against TNBC cells while being less toxic to healthy cells, hinting at herbal-based drug development for breast cancer.
- Upreti S et al (2023).
- Med Oncol.
- PubMed:
- 37806999